Chun-Yen Yu

Chun-Yen Yu

Auto-generated profile, based on publicly available information

Chun-Yen Yu

Department of Diagnostic Radiology, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2020 in Diagnostic and Interventional Radiology
Verified
Journal Article
Closed access
SLSieh-Yang Lee
Sieh-Yang Lee
HOHsin‐You Ou
Hsin‐You Ou
CYChun-Yen Yu
Chun-Yen Yu
THTung-Liang Huang
Tung-Liang Huang
LTLeo Leung-Chit Tsang
Leo Leung-Chit Tsang
YCYu-Fan Cheng
Yu-Fan Cheng
PURPOSE We aimed to compare the safety and effectiveness of 100-300 mu m versus 300-500 mu m drug-eluting bead transarterial chemoembolization (DEB-TACE) and to investigate the impact of tumor and feeding artery size on treatment outcome of different particle sizes in the treatment of hepatocellular carcinoma (HCC). METHODS This retrospective cohort study enrolled 234 consecutive patients who underwent TACE using 100-300 mu m DEB (Group A, n=75) and 300-500 mu m DEB (Group B, n=159) in a tertiary center between August 2012 and March 2017. Initial treatment response and adverse events were assessed using modified Response Evaluation Criteria in Solid Tumors (mRECIST) and National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 5.0, respectively. RESULTS A total of 704 HCCs in 234 patients were evaluated. The average index tumor size was 3.8 cm. Multivariate analysis showed that tumor size, lobe inv olvement, particle size, and tumor location were significant predictive factors of complete response. The overall rate of complete response in groups A and B were 56.0% and 33.3% (P = 0.001), respectively. Group A had higher complete response rate than group B in the subgroup of BCLC B with tumor = 0.9 mm (55.2% vs. 30.9%; P = 0.014). There were fewer major complications in group A compared with group B (0% vs. 6.9%, P = 0.018). CONCLUSION TACE with 100-300 mu m DEB is associated with better initial treatment response and fewer major complications compared with 300-500 mu m. Our study also highlights the impact of tumor characteristics on treatment outcome of different DEB size, which might help to select the optimal sphere size for TACE in the treatment of HCC.

1 September 2022 in Diagnostic and Interventional Radiology
Verified
Journal Article
Open access
CLChih Ying Lee
Chih Ying Lee
WLWei-Xiong Lim
Wei-Xiong Lim
CCChao-Long Chen
Chao-Long Chen
CYChee-Chien Yong
Chee-Chien Yong
CYChun-Yen Yu
Chun-Yen Yu
HOHsin‐You Ou
Hsin‐You Ou
Intractable ascites (IA) is an uncommon but challenging complication after liver transplantation. Splenic artery embolization (SAE) modulates the splenic artery and regulates portal flow. This study aimed to evaluate the efficacy and safety of SAE using the Amplatzer vascular plug (AVP) versus coil embolization for post-living-donor liver transplantation (LDLT) IA. This retrospective study evaluated consecutive patients from 1 center who received LDLT (n = 1410) between March 2006 and August 2019. The inclusion criteria for SAE were splenomegaly with IA after LDLT. Totally 15 patients underwent SAE for post-LDLT IA. Eleven patients who received AVP embolization (age, 51.2 ± 15.1 years; range, 8-63 years; 5 men and 6 women) were compared with 4 patients receiving coil embolization (age, 30.8 ± 30.8 years; range, 1.5-63 years; 2 men and 2 women). AVP and coil embolization both significantly reduced portal vein hyperflow (plug/coil; P < .001/.006) and decreased ascites volume (plug/coil; P < .003/.042). The benefits of AVP embolization included shorter procedure time (P = .029), significantly reduced splenic volume (P = .012), increased liver volume (P = .012), decreased spleen/liver ratio (P = .012), and improvement of pancytopenia (P = .008) due to secondary hypersplenism. No significant differences were found between the two groups in the length of hospital stay or complications such as splenic infarction, pancreatitis, or sepsis. SAE using AVP and coil embolization provide effective and safe methods for managing patients with IA after LDLT. AVP embolization may be more efficient than coil embolization, providing more effective reduction of ascites volume and the advantages of shortened procedure time and improvement of hypersplenism.

1 January 2026 in Korean Journal of Radiology
Verified
Journal Article
Open access
PDF file
PHPo-Hsun Huang
Po-Hsun Huang
HOHsin‐You Ou
Hsin‐You Ou
LTLeung-Chit Tsang
Leung-Chit Tsang
HHHsien-Wen Hsu
Hsien-Wen Hsu
WLWei-Xiong Lim
Wei-Xiong Lim
YCYu-Fan Cheng
Yu-Fan Cheng
Huang PH, et al. Korean J Radiol. 2026 Sep;27(9):890-896. https://doi.org/10.3348/kjr.2026.0364